Skip to content
Research Article Open access CC BY 3.0

Long Term Anti-Diabetic, Anti-Hyperlipidaemic and Anti-Atherogenic Effects of Carica papaya Leaves in Streptozotocin Diabetic Rats

Omonkhua Akhere A., Onoagbe Iyere O., Ajileye Afolabi F., Aladegboye Lekan O., Adetoboye Ayodeji R.

European Journal of Medicinal Plants · pp. 508–519 · Published 2 Aug 2013

10.9734/EJMP/2013/4097

Abstract

Aim: To evaluate the long term (24 weeks) anti-diabetic, anti-hyperlipidaemic and anti-atherogenic effects of aqueous leaf extract of Carica papaya in streptozotocin (STZ) diabetic rats. Study Design: The effect of daily oral administration of C. papaya aqueous leaf extract in streptozotocin diabetic rats was monitored for 24 weeks by assessing fasting blood sugar and serum lipid profile. Place and Duration of Study: Department of Biochemistry Laboratory and Central Research Laboratory, Adekunle Ajasin University, Akungba-Akoko, Ondo State, Nigeria. March to October, 2009. Methodology: 24 rats in three groups, normal control (group 1), diabetic control (group 2) and C. papaya treated diabetic rats, TDR (group 3) were used for this study. Body weight, fasting blood sugar (FBS), total cholesterol, total triglycerides, LDL-cholesterol and HDL-cholestrol, as well as atherogenic index (AI) and coronary risk index (CRI), were assessed periodically in the serum for 24 weeks. Results: Treatment of STZ diabetic rats with C. papaya leaf extract produced significant (P<.05) reductions in FBS from week 2 of treatment. Normoglycaemia was attained in week 8 and sustained till week 24. Significant (P<.05) reductions in serum total cholesterol and LDL-cholesterol concentrations were also observed for most of the points monitored while HDL-cholesterol was significantly (P<.05) increased. The high AI and CRI caused by STZ diabetes was significantly (P<.05) reduced in the C. papaya treated diabetic rats. Conclusion: The findings from this study substantiate the long term potential and traditional usage of C. papaya for antidiabetic and antihyperlipidaemic effects.  

Carica papaya antidiabetic anti-hyperlipidaemic anti-atherogenic medicinal plant

Cited by 13

The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders

Trevor T. Nyakudya, Thulani Tshabalala, Rachael Dangarembizi · Molecules · 2020

Antidiabetic plants used among the ethnic communities of Unakoti district of Tripura, India

Ramananda Ghosh Tarafdar, Sushmita Nath, Anupam Das Talukdar · Journal of Ethnopharmacology · 2015

Effect of chitosan on cardio-metabolic risk factors induced by high fat diet in rats

Regina Ngozi Ugbaja, Beno Okechukwu Onunkwor, Emmanuel Ifeanyichukwu Ugwor · Nutrition & Food Science · 2022

A review: Antihyperglycemic plant medicines in management of diabetes

Kiran Bhagour, Dharmendra Arya, R.S. Gupta · Acupuncture and Related Therapies · 2016

Carica papaya: comprehensive overview of the nutritional values, phytochemicals and pharmacological activities

Oluwaseun Ruth Alara, Nour Hamid Abdurahman, John Adewole Alara · Advances in Traditional Medicine · 2020

Showing 12 of 13 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

13

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.